Milestone Media

Ally, DC, Milestone Media, and Warner Bros. discovery reveal NASCAR paint scheme inspired by The Milestone Initiative

Retrieved on: 
Wednesday, June 29, 2022
Warner Bros. Television Studios, Discovery Channel, HGTV, UNIVERSE, SVP, Chevrolet Camaro, Warner Bros. Interactive Entertainment, Ally Financial, Social media, Superhero, Bowman, Publishing, Insurance, Adult, Static Shock, CNN, Hand, Chevrolet, TNT, Atlanta Motor Speedway, Trend analysis, FDIC, NYSE, TLC, Milestone Media, Travel Channel, Warner, Science Channel, Hogar de HGTV, Blood Syndicate, Television, NASCAR, TBS, Quakers, HBO, HBO Max, General manager, Cartoon Network, News, OWN, TruTV, Investigation Discovery, Icon, Warner Bros. Pictures, Discovery, Quaker State, Sale, Equal housing lender, Milestone, DIY Network, History, Magnolia, Awareness, Culture, No, Static, Public relations, Hope, Electricity, Food Network, Sales, Entertainment, Online shopping, Atlanta, Eurosport, Ally, New Line Cinema

48 Chevrolet Camaro ZL1 1LE of Hendrick Motorsports, in support of their joint program, The Milestone Initiative .

Key Points: 
  • 48 Chevrolet Camaro ZL1 1LE of Hendrick Motorsports, in support of their joint program, The Milestone Initiative .
  • Driver Alex Bowman will race in the electrifying paint scheme for the Quaker State 400 on July 10 at Atlanta Motor Speedway.
  • Announced in 2021, The Milestone Initiative is collaborative program between Ally, DC, Milestone Media and Warner Bros.
  • Designed in collaboration with DC's creative services team, the car features Milestone Super Hero Static to drive awareness and interest for The Milestone Initiative among NASCAR fans.

Ally launches widest-reaching campaign in brand history: we're all better off with an ally

Retrieved on: 
Monday, October 18, 2021
Dream, Athlete, Family, WarnerMedia, Public relations, Friends, Milestone Media, Black, Ally, OOH, NASCAR, City, Gasoline, Nightclub

"The last 18 months have shown us how incredibly important it is to have strong allies in our lives, from family and friends to neighbors and co-workers," said Andrea Brimmer, chief marketing and public relations officer at Ally. "At Ally, our customers shared how important it was we were there for them at the start of the pandemic, helping them navigate all of their moments – big and small -- that require managing their money. Their words and feedback helped us crystallize the meaning of our brand promise and served as the inspiration for this new campaign."

Key Points: 
  • CHARLOTTE, N.C., Oct. 18, 2021 /PRNewswire/ -- Last summer, Ally introduced a campaign that shined a spotlight on the importance of allies in helping elite unsponsored U.S. athletes pursue their dreams.
  • Extending that essential message to everyone, Ally today launched its largest campaign ever, reinforcing the idea that "we're all better off with an ally" in the moments that matter most.
  • Their words and feedback helped us crystallize the meaning of our brand promise and served as the inspiration for this new campaign."
  • The "We're All Better Off with an Ally" campaign will be prominently featured throughout all of Ally's brand programming and properties.

The Linda Baker Team Partners With Side To Form Milestone Realty and Deliver Tailored Solutions

Retrieved on: 
Friday, June 18, 2021
Milestone Media

The association will ensure that Milestone Realty, an innovative and collaborative firm, is powered by the most advanced platform in the industry.

Key Points: 
  • The association will ensure that Milestone Realty, an innovative and collaborative firm, is powered by the most advanced platform in the industry.
  • The Linda Baker Team will continue to deliver top-tier client care and full-service offerings through its new brand, Milestone Realty.
  • The firm is led by an 18-year industry veteran, Linda Baker, who has helped hundreds of clients through the milestone event of buying or selling a home.
  • Additionally, Milestone Realty will join an exclusive group of Side partners, tapping into an expansive network from coast to coast.

Creatd's Vocal Platform Surpasses 1 Million Creators

Retrieved on: 
Monday, May 24, 2021
Economy of New York City, NASDAQ, Milestone Media, Jeremy Frommer, MileStone Inc., Finance, Businesspeople, Economy of the United States

FORT LEE, N.J., May 24, 2021 /PRNewswire/ --Creatd, Inc. (Nasdaq CM: CRTD) ("Creatd" or the "Company"), today announced that its flagship platform, Vocal , has reached 1 million creators ahead of schedule.

Key Points: 
  • FORT LEE, N.J., May 24, 2021 /PRNewswire/ --Creatd, Inc. (Nasdaq CM: CRTD) ("Creatd" or the "Company"), today announced that its flagship platform, Vocal , has reached 1 million creators ahead of schedule.
  • Commenting on the Company's latest milestone, Creatd CEO Jeremy Frommer said, "This 1 million creator milestone signifies Vocal's flourishing creator community, but also has implications that extend far beyond that.
  • Having now surpassed the 1 million creator mark, we expect this milestone will yield an increase in the pace of conversions to the Vocal+ premium tier going forward."
  • Creatd, Inc. (Nasdaq CM: CRTD) is a creator-first technology company and the parent company of the Vocal platform.

Milestone Scientific Announces Promotion of Arjan Haverhals to CEO

Retrieved on: 
Thursday, May 13, 2021
Milestone Media, MileStone Inc., Milestone, Video game companies

Mr. Kahn will succeed Joseph D\xe2\x80\x99Agostino who retired from Milestone Scientific last month.\nLeonard Osser, Interim CEO of Milestone Scientific, stated, "I am very pleased to announce Arjan\xe2\x80\x99s promotion to CEO of Milestone Scientific.

Key Points: 
  • Mr. Kahn will succeed Joseph D\xe2\x80\x99Agostino who retired from Milestone Scientific last month.\nLeonard Osser, Interim CEO of Milestone Scientific, stated, "I am very pleased to announce Arjan\xe2\x80\x99s promotion to CEO of Milestone Scientific.
  • Scott brings more than 40 years of leadership with a proven track record in corporate and finance and operations.
  • Haverhals has served as Milestone Scientific\'s President since September 2020 and as President and Chief Executive Officer of Milestone Scientific\xe2\x80\x99s Dental Division, Wand Dental Inc., since June 2020.
  • Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.\n'

ALYI Announces RevoltTOKEN Electric Vehicle Ecosystem Milestone

Retrieved on: 
Tuesday, January 12, 2021
Milestone Media

DALLAS, Jan. 12, 2021 /PRNewswire/ --Alternet Systems, Inc. (USOTC: ALYI) today announced their financing partner, RevoltTOKEN has achieved a major milestone.

Key Points: 
  • DALLAS, Jan. 12, 2021 /PRNewswire/ --Alternet Systems, Inc. (USOTC: ALYI) today announced their financing partner, RevoltTOKEN has achieved a major milestone.
  • RevoltTOKEN CEO Henryk Dabrowski plans to publish an update this Friday, January 15th, 2021 to detail the milestone and provide the latest update on progress toward the planned ICO to fund the ALYI electric vehicle ecosystem.
  • For more information and to stay up to date on RevoltTOKEN's latest developments, please visit www.revolttoken.com .
  • The statements reflect the Company's current views with respect to future events that involve risks and uncertainties.

Milestone Scientific Schedules Third Quarter 2020 Conference Call

Retrieved on: 
Tuesday, November 3, 2020
Telecommunications, Lluís Companys, Toll-free telephone number, Area code 246, Mixed liquor suspended solids, Milestone Media, Conference call, MileStone Inc.

ROSELAND, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 17, 2020 to discuss the Companys financial results for the third quarter ended September 30, 2020, as well as the Companys corporate progress and other developments.

Key Points: 
  • ROSELAND, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 17, 2020 to discuss the Companys financial results for the third quarter ended September 30, 2020, as well as the Companys corporate progress and other developments.
  • The conference call will be available on the Companys website at www.milestonescientific.com , or via telephone by dialing toll free 877-407-0778 for U.S. callers, or +1 201-689-8565 for international callers.
  • Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications.
  • Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless.

Milestone Reporting Announces Free Online Video Teleconferencing

Retrieved on: 
Monday, October 19, 2020
Telecommunications, Articles, Assistive technology, Health informatics, Teleconferencing, Health, Smartphones, Video, Videotelephony, Cision, Milestone Media, Quarantine

ORLANDO, Fla., Oct. 19, 2020 /PRNewswire-PRWeb/ --Milestone Reporting has announced that it will provide online videoconferencing services for free to all attorneys in need of remote deposition services.

Key Points: 
  • ORLANDO, Fla., Oct. 19, 2020 /PRNewswire-PRWeb/ --Milestone Reporting has announced that it will provide online videoconferencing services for free to all attorneys in need of remote deposition services.
  • "We are going to continue to provide free online videoconferencing until at least the end of February 2021," said Mike McDonner, Milestone's President.
  • "These services will remain free until a vaccine is developed and quarantine rules are completely lifted."
  • Back in late March of 2020, Milestone recognized the risks associated with the Coronavirus and was the first reporting company to actively push attorneys to take depositions remotely.

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Retrieved on: 
Tuesday, September 8, 2020
Milestone Media

MONTREALandCHARLOTTE, N.C., Sept. 8, 2020 /PRNewswire/ --Milestone Pharmaceuticals Inc.(Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced thatJoseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:

Key Points: 
  • MONTREALandCHARLOTTE, N.C., Sept. 8, 2020 /PRNewswire/ --Milestone Pharmaceuticals Inc.(Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced thatJoseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:
    The H.C. Wainwright & Co. 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 11:30 a.m. Eastern Time
    The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23, 2020 at 2:30 p.m. Eastern Time
    A live webcast of the presentations can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com .
  • An archived replay of the webcasts will be available on the same website for approximately 30 days following the presentations.
  • Milestone Pharmaceuticalsis a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines.Milestone Pharmaceuticalsoperates inCanadaandthe United States.
  • For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.

Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®

Retrieved on: 
Tuesday, August 25, 2020
Knight Therapeutics, Royalty payment, Milestone Media

MONTREAL and BOCA RATON, Fla, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (Knight) and TherapeuticsMD, Inc. (NASDAQ: TXMD) (TherapeuticsMD) announced today the approval of IMVEXXYby Health Canada.

Key Points: 
  • MONTREAL and BOCA RATON, Fla, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (Knight) and TherapeuticsMD, Inc. (NASDAQ: TXMD) (TherapeuticsMD) announced today the approval of IMVEXXYby Health Canada.
  • The approval of IMVEXXY by Health Canada marks a significant new milestone for Knight and we could not be more pleased as they bring this new treatment option to women in Canada, said Robert Finizio, Chief Executive Officer of TherapeuticsMD.
  • Knight and TherapeuticsMD signed a licensing agreement in July 2018 pursuant to which TherapeuticsMD granted Knight the exclusive Canadian commercialization rights to IMVEXXY and BIJUVA(estradiol and progesterone) capsules.
  • Under the terms of the licensing agreement related to IMVEXXY in Canada, Knight will pay TherapeuticsMD a milestone fee for the regulatory approval in Canada of IMVEXXY, sales milestone fees based upon certain aggregate annual sales of IMVEXXY in Canada, and royalties based on aggregate annual sales of IMVEXXY in Canada.